Please login to the form below

Not currently logged in
Email:
Password:

Empliciti

This page shows the latest Empliciti news and features for those working in and with pharma, biotech and healthcare.

Darzalex powers ahead with frontline myeloma approval in Europe

Darzalex powers ahead with frontline myeloma approval in Europe

A rival biologic in multiple myeloma is BMS and AbbVie’s  Empliciti (elotuzumab), though this is trailing far behind Darzalex in sales, earning a more modest $64m in Q2.

Latest news

More from news
Approximately 6 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics